Risk Estimation of Down’s Syndrome and Economic Evaluation for Its Screening
博士 === 國立臺灣大學 === 流行病學研究所 === 92 === Down’s syndrome (trisomy 21) is the most common chromosomal anomaly worldwide, and the most commonly recognized genetic cause of mental retardation. The incidence of Down’s syndrome (DS) is 1.2-1.7 per 1000 live born, and the total prevalence was about 1.5 per 10...
Main Authors: | Hsiao-Lin Hwa, 華筱玲 |
---|---|
Other Authors: | Tony Hsiu-Hsi Chen |
Format: | Others |
Language: | en_US |
Published: |
2004
|
Online Access: | http://ndltd.ncl.edu.tw/handle/78556589581537745835 |
Similar Items
-
Informed Consent for Antenatal Serum Screening for Down Syndrome
by: Hsiao-Lin Hwa, et al.
Published: (2010-03-01) -
Economic issues in the provision of antenatal screening for Down's syndrome
by: Deverill, Mark
Published: (2008) -
Cost-effectiveness Evaluation of Down Syndrome Screening
by: Ing-LuenShyu, et al.
Published: (2019) -
Economic evaluation of antenatal screening for Down Syndrome and serious congenital heart defects in Norway
by: Movik, Espen
Published: (2014) -
Prenatal Screening for Down Syndrome
by: Ounjai Kor-anantakul
Published: (2017-04-01)